Luna Chemicals Co.,Ltd. markets and manufactures world-class quality Active Pharmaceutical Ingredients and intermediate for 30 years.With turn over of $60 million in 2020, we expanded our business on CDMO for more opportunities. Luna started CDMO with our 2 main partners: One is Huadong Medicine who is Top 10 Chinese pharmaceutical company, the other is Institute of Zhejiang University-Quzhou who is  representative of most advanced Institution in China. Luna Chemicals and Huadong established strategic cooperation in 2020. Huadong is a listed pharmaceutical company who focused on Bio-Medicine, New Molecule & Finished Dosage. Huida is sub-division for Bio product in Huadong,  a wholly subsidiary of Huadong,  Who mainly organize the inner outer cooperation with professional R&D of Huadong, covering on Anti-tumor natural compounds, Anti-bacterial compounds, Anti-parasitic compounds, and Comprehensive healthcare products for human or animal. Among these, Anti-tumor natural compounds is the top priority ADC products, like Exatecan mesylate which innovator is Daiichi Sankyo and Plitidepsin which innovator is PharmaMar.  Recent research showed Plitidepsin has 20 times more effective than Remdesivir on COVID-19. Besides, Huida is No.1 supplier of raw material for Pfizer's COVID-19 vaccine. They succeeded in CDMO evaluation by Pfizer with quickest qualified products and exellent quality. Pilot plant of Institute of Zhejiang University-Quzhou will be ready at August,It's regarded as the model CDMO facility for local government. Chemistry industry of Zhejiang is the most advanced in China with strong support from local government on all policies. The most important is teams of these professors and PHDs, with their intelligence, are long-term partners of Luna chemicals. Luna Chem, together with above partners, are regarded as professional and effective on the R&D of cutting-edge technology. We hope we will be the perfect partner of your CDMO.